[Federal Register Volume 63, Number 23 (Wednesday, February 4, 1998)]
[Notices]
[Pages 5806-5807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-2677]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[INFO-98-11]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 639-7090.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques for other
forms of information technology. Send comments to Wilma Johnson, CDC
Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA
30333. Written comments should be received within 60 days of this
notice.
Proposed Projects
1. A Longitudinal Study of Lead Poisoning from the Maternal Infant
Relationship Through Early Childhood--New--
The Agency for Toxic Substances and Disease Registry (ATSDR) is
mandated pursuant to the 1980 Comprehensive Environmental Response
Compensation and Liability Act (CERCLA), and its 1986 Amendments, The
Superfund Amendments and Reauthorization Act (SARA), to prevent or
mitigate adverse human health effects and diminished quality of life
resulting from exposure to hazardous substances in the environment.
Lead exposure has been associated with negative pregnancy outcomes in
humans, including low birth weight, spontaneous abortion, congenital
malformation, and various neurological effects in newborns and young
children. The level of lead considered to be toxic has been lowered
over the years by major research groups, organizations, and agencies.
While lead has been shown to affect all organs, the brain or nervous
system seems to be the most sensitive to lead toxicity, especially in
young children. Blood lead levels as low as 10 g/dL have been
shown to result in delayed cognitive development, reduced IQ scores,
and impaired hearing.
This study, originally approved by OMB in 1995, examines the long-
term effects of low and marginal toxic blood lead levels in neonates
and preschool African-American children in the Atlanta area. This study
is divided into two components, (i) Prevalence of lead exposure in
children of preschool age and (ii) longitudinal health effects of low
and marginal lead exposure. These studies are conducted concurrently.
The primary focus of the prevalence study is the evaluation of the
relationship between socio-economic status, elemental blood lead levels
within the home environment, and blood lead levels of preschool aged
children. The objective of the longitudinal study is the evaluation of
the relationship between lead levels found in maternal and cord blood
and adverse health effects in the infant, including deficits in
behavioral, cognitive and physical development. To correlate cognitive
and behavioral development with varying blood lead levels, each newborn
is to undergo a series of psychometric testing at birth, then again at
6 months, 1, and 2 years of age. Evaluations of physician development
will be conducted by reviewing the medical records of each newborn
within the first year after birth.
This request is for a 3-year extension of the current OMB approval;
however we are requesting a new OMB authority (and number) as the old
number (0923-0015) will now apply only to the Substance Specific
Applied Research Program (AMHPS) [King/Drew Lead Study in-Person
Interview, Lead and Hypertension Screening Questionnaire/Risk Factor
Questionnaire]. The requests for OMB approval for the two studies has
been separated, with the King/Drew investigation retaining the old OMB
number (0923-0015).
[[Page 5807]]
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
Study Respondents No. of responses/ response (in Total burden
respondents respondent hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Prevalence........................ Households........... 100 1 0.75 75
Daycare Centers...... 10 1 0.25 2.5
Longitudinal...................... Pregnant Women....... 300 3.5 0.167 175.35
Infants.............. 300 7 0.524 1,100.40
-----------------------------------------------------------------------------
Total......................... ..................... ........... ............ ............ 1,353.25
----------------------------------------------------------------------------------------------------------------
2. Weekly and Annual Morbidity and Mortality Reports--In 1878
Congress authorized the U.S. Marine Hospital Service (later re-named
the U.S. Public Health Service) to collect morbidity reports on
cholera, smallpox, plague, and yellow fever from U.S. consuls overseas;
this information was to be used for instituting quarantine measures to
prevent the introduction and spread of these diseases in the United
States. In 1879, a specific Congressional appropriation was made for
the collection and publication of reports of these notifiable diseases.
The authority for weekly reporting and publication was expanded by
Congress in 1893 to include data from state and municipal authorities
throughout the U.S. To increase the uniformity of the data, Congress
enacted a law in 1902 directing the Surgeon General of the Public
Health Service to provide forms for the collection and compilation of
data and for the publication of reports at the national level.
In 1961, responsibility for the collection of data on nationally
notifiable diseases and deaths in 121 U.S. cities was transferred from
the National Office of Vital Statistics to CDC. For 37 years the MMWR
has consistently served as CDC's main communication mode for disease
outbreaks and trends in health and health behavior. In collaboration
with the Council of State and Territorial Epidemiologists (CSTE), CDC
has demonstrated the efficiency and effectiveness of computer
transmission of data. The data collected electronically for publication
in the MMWR provides information which CDC and State epidemiologists
use to detail and more effectively interrupt outbreaks. Reporting also
provides the timely information needed to measure and demonstrate the
impact of changed immunization laws or a new therapeutic measure. Users
of data include, but are not limited to, congressional offices, state
and local health agencies, health care providers, and other health
related groups.
The dissemination of public health information is accomplished
through the MMWR series of publications. The publications consist of
the MMWR, the CDC Surveillance Summaries, the Recommendations and
Reports, and the Annual Summary of Notifiable Diseases. The total cost
to respondents is estimated to be $48,100.
----------------------------------------------------------------------------------------------------------------
No. of Avg. burden/
Respondents No.of responses/ response (in Total burden
respondents respondent hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
State and local health departments.............. 178 52 .45 4,165
---------------------------------------------------------------
Total....................................... .............. .............. .............. 4,165
----------------------------------------------------------------------------------------------------------------
Dated: January 29, 1998.
Wilma G. Johnson,
Acting Associate Director for Policy Planning And Evaluation, Centers
for Disease Control and Prevention (CDC).
[FR Doc. 98-2677 Filed 2-3-98; 8:45 am]
BILLING CODE 4163-18-P
